BioCentury
ARTICLE | Company News

Inverness, Blanchette Rockefeller Neurosciences Institute deal

June 8, 2009 7:00 AM UTC

Inverness received an option to license worldwide rights to the institute's technology covering its undisclosed Alzheimer's disease biomarker to diagnose and predict disease progression and monitor tr...